Compare DLPN & NAII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DLPN | NAII |
|---|---|---|
| Founded | 1996 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.4M | 21.2M |
| IPO Year | N/A | 1987 |
| Metric | DLPN | NAII |
|---|---|---|
| Price | $1.65 | $4.85 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 42.8K | 16.9K |
| Earning Date | 11-12-2025 | 02-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $53,371,115.00 | ★ $134,440,000.00 |
| Revenue This Year | $10.62 | N/A |
| Revenue Next Year | $13.78 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 3.86 | ★ 19.00 |
| 52 Week Low | $0.75 | $2.57 |
| 52 Week High | $1.88 | $4.87 |
| Indicator | DLPN | NAII |
|---|---|---|
| Relative Strength Index (RSI) | 58.60 | 76.61 |
| Support Level | $1.59 | $3.14 |
| Resistance Level | $1.68 | $3.55 |
| Average True Range (ATR) | 0.08 | 0.24 |
| MACD | 0.02 | 0.13 |
| Stochastic Oscillator | 92.11 | 76.92 |
Dolphin Entertainment Inc is an independent entertainment marketing and production company. It provides strategic marketing and publicity services to many of the top brands, both individual and corporate, in the motion picture, television, music, gaming, culinary, hospitality, and lifestyle industries. It operates in two reportable segments: Entertainment publicity and marketing and Content production. It generates the majority of its revenue from the Entertainment publicity and marketing segment which provides clients with diversified marketing services, including public relations, entertainment and hospitality content marketing, strategic marketing consulting, and content production of marketing materials.
Natural Alternatives International Inc is engaged in formulating, manufacturing, and marketing nutritional supplements. It offers vitamins, minerals, herbs, and other supplements, as well as other healthcare products to customers within the United States and internationally. Its business activity is operated through Private-Label Contract Manufacturing and Patent & Trademark Licensing segment. The company derives the majority of revenue from Private-Label Contract Manufacturing which is engaged in providing manufacturing services to companies that market and distribute nutritional supplements and other healthcare products, whereas the Patent and Trademark Licensing segment includes royalty income from its license and supply agreements associated with the sale.